Sort
39,280 grants matching “leukemia”
PPM1D in Clonal Hematopoiesis and Malignancies
$621,577Margaret Goodell · Baylor College Of Medicine · R01 · FY2019 · CA
MACROMOLECULAR STRUCTURE DETERMINATION - GENERAL USERS
$621,537Robert M Sweet · Brookhaven Science Assoc-Brookhaven Lab · P41 · FY2008 · RR
O-Glycosylation of Epidermal Growth Factor-like Modules
$621,532Robert S. Haltiwanger · State University New York Stony Brook · R01 · FY2010 · GM
Development of P2Y Receptor Ligands
$621,513Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK
Using Mass Spectroscopy to Characterize Transcription Proteins and F2-Isoprostane
$621,470Bettye Henninton · Tougaloo College · P20 · FY2010 · MD
Targeting Alloreactivity for Leukemia Eradication
$621,411Stanley R Riddell · Fred Hutchinson Cancer Research Center · P01 · FY2008 · CA
Mesenchymal Regulation of Osteogenesis
$621,390Richard A Schneider · University Of California, San Francisco · R01 · FY2024 · DE
Pharmacogenetic Determinants of Vincristine Toxicity and Response
$621,364Jamie L Renbarger · Indiana University Indianapolis · R01 · FY2012 · HD
Sensitive, Integrating Multi-Waveguide Biosensor
$621,342Cha-Mei Tang · Creatv Microtech, Inc. · R44 · FY2007 · CA
Exercise and QUality diet After Leukemia
$621,296Emily Smith Tonorezos · Sloan-Kettering Inst Can Research · R01 · FY2017 · CA
Using Mass Spectroscopy to Characterize Transcription Proteins and F2-Isoprostane
$621,221Bettye Henninton · Tougaloo College · P20 · FY2008 · MD
Safety and Feasibility of Cultivated Autologous Limbal Epithelial Cell (CALEC) Transplantation in the Treatment of Limbal Stem Cell Deficiency
$621,211Jerome Ritz · Dana-Farber Cancer Inst · UG1 · FY2017 · EY
Linking insertional mutagenesis and cell function to improve CAR T cell therapy
$621,091Frederic D Bushman · University Of Pennsylvania · R01 · FY2021 · CA
Developing Mathmatical Framework to Uncover the Sequence of Genetic Events During
$621,050Franziska Michor · Dana-Farber Cancer Inst · U54 · FY2013 · CA
Comprehensive Approach to Improve Medicine Adherence in Pediatric Leukmia
$620,968Smita Bhatia · University Of Alabama At Birmingham · R01 · FY2016 · CA
Targeting neuronal transport to ameliorate vincristine neurotoxicity
$620,870Shuiying Hu · Ohio State University · R01 · FY2024 · CA
NCI Community Oncology Research Program (NCORP) Community Sites
$620,783Albert Denittis · Lankenau Institute For Medical Research · UG1 · FY2016 · CA
CPML - Core C: Bioinformatics & Biostatistical Core
$620,755Jinghui Zhang · St. Jude Children'S Research Hospital · P50 · FY2018 · GM
Lnk Regulatory Functions in Hematopoietic Stem Cells
$620,738Wei Tong · Children'S Hosp Of Philadelphia · R01 · FY2019 · HL
Developing novel therapies to improve blood stem cell transplantation outcomes
$620,713Ramiro Garzon · University Of Utah · R01 · FY2024 · HL
Phase 1 Evaluation of Enhanced Natural Killer Cells as a Treatment Strategy in Non-Small cell Lung Cancer Patients Refractory to PD-1/PD-L1 Immune Checkpoint Inhibitors
$620,673Miguel Angel Villalona · Beckman Research Institute/City Of Hope · R01 · FY2022 · CA
Imaging Disease Heterogeneity and Response to Therapy in Myelofibrosis
$620,650Brian D. Ross · University Of Michigan At Ann Arbor · R01 · FY2020 · CA
Imaging Disease Heterogeneity and Response to Therapy in Myelofibrosis
$620,650Brian D. Ross · University Of Michigan At Ann Arbor · R01 · FY2021 · CA
Imaging Disease Heterogeneity and Response to Therapy in Myelofibrosis
$620,650Brian D. Ross · University Of Michigan At Ann Arbor · R01 · FY2019 · CA
Core A: Administrative Core
$620,649Karen R Rabin · Baylor College Of Medicine · U54 · FY2025 · CA